XML 56 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair value of financial instruments and marketable securities - Narrative (Details)
9 Months Ended 12 Months Ended
Sep. 30, 2018
USD ($)
$ / shares
Dec. 31, 2017
USD ($)
$ / shares
Aug. 23, 2018
USD ($)
Apr. 08, 2018
$ / shares
Aug. 31, 2015
USD ($)
Financial assets and liabilities measured at fair value on recurring basis          
Transfers of assets between Level 1 and Level 2 of the fair value measurement hierarchy $ 0 $ 0      
Realized gain (loss) 0 0      
Fair value of shares (in dollars per share) | $ / shares       $ 27.04  
Development milestone payments which the entity is obligated to pay 4,500,000        
Estimated fair value of deferred consideration payable $ 38,200,000 $ 0      
Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Fair value of shares (in dollars per share) | $ / shares $ 47 $ 16.68      
Minimum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, exercise price (in dollars per share) | $ / shares   128.00      
Minimum | Commitments          
Financial assets and liabilities measured at fair value on recurring basis          
Milestone, potential achievements, product sales 25.00%        
Maximum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, exercise price (in dollars per share) | $ / shares   2,520.00      
Maximum | Commitments          
Financial assets and liabilities measured at fair value on recurring basis          
Milestone, potential achievements, product sales 89.00%        
SARs          
Financial assets and liabilities measured at fair value on recurring basis          
Fair value of shares (in dollars per share) | $ / shares $ 47 $ 16.68      
3.00% Convertible senior notes due 2022 | Convertible debt          
Financial assets and liabilities measured at fair value on recurring basis          
Principal $ 150,000,000 $ 150,000,000     $ 150,000,000.0
Interest rate         3.00%
Fair value of convertible notes $ 172,900,000 $ 115,700,000      
Measurement Input, Price Volatility | Minimum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.51 0.69      
Measurement Input, Price Volatility | Maximum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.54 0.69      
Measurement Input, Price Volatility | SARs | Minimum          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.45 0.31      
Measurement Input, Price Volatility | SARs | Maximum          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.54 0.70      
Measurement Input, Risk Free Interest Rate | Minimum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.0259 0.0189      
Measurement Input, Risk Free Interest Rate | Maximum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.0259 0.0189      
Measurement Input, Risk Free Interest Rate | SARs | Minimum          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.0219 0.0128      
Measurement Input, Risk Free Interest Rate | SARs | Maximum          
Financial assets and liabilities measured at fair value on recurring basis          
Derivative liability, measurement input 0.0270 0.0189      
Measurement Input, Strike Price | Minimum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, exercise price (in dollars per share) | $ / shares 128.00        
Measurement Input, Strike Price | Maximum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, exercise price (in dollars per share) | $ / shares 2,520.00        
Measurement Input, Strike Price | SARs | Minimum          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, exercise price (in dollars per share) | $ / shares 6.76 6.76      
Measurement Input, Strike Price | SARs | Maximum          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, exercise price (in dollars per share) | $ / shares 30.86 30.86      
Measurement Input, Expected Term | Minimum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, term 10 months 2 days 1 year 7 months 6 days      
Measurement Input, Expected Term | Maximum | Warrants          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, term 11 months 23 days 1 year 8 months 12 days      
Measurement Input, Expected Term | SARs | Minimum          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, term 3 months 4 days 0 days      
Measurement Input, Expected Term | SARs | Maximum          
Financial assets and liabilities measured at fair value on recurring basis          
Warrants, term 1 year 3 months 4 days 2 years      
Agilis          
Financial assets and liabilities measured at fair value on recurring basis          
Development milestone payments which the entity is obligated to pay $ 40,000,000   $ 40,000,000    
Estimated fair value of deferred consideration payable     38,200,000    
Agilis | Commitments          
Financial assets and liabilities measured at fair value on recurring basis          
Development milestone, potential achievements $ 20,000,000        
Agilis | Minimum          
Financial assets and liabilities measured at fair value on recurring basis          
Milestone, potential achievements, product sales 2.00%        
Agilis | Minimum | Commitments          
Financial assets and liabilities measured at fair value on recurring basis          
Milestone, potential achievements, product sales 2.00%        
Development milestone, potential achievements $ 0        
Milestone, potential achievements, priority review voucher amount 0        
Milestone, potential achievements, net sales amount $ 0        
Agilis | Maximum          
Financial assets and liabilities measured at fair value on recurring basis          
Milestone, potential achievements, product sales 6.00%        
Development milestone payments which the entity is obligated to pay $ 60,000,000        
Milestone, potential achievements, priority review voucher amount 535,000,000        
Milestone, potential achievements, net sales amount $ 150,000,000        
Agilis | Maximum | Commitments          
Financial assets and liabilities measured at fair value on recurring basis          
Milestone, potential achievements, product sales 6.00%        
Development milestone, potential achievements $ 20,000,000        
Milestone, potential achievements, priority review voucher amount 535,000,000        
Milestone, potential achievements, net sales amount 150,000,000        
Non-collaborative Arrangement Transactions | Agilis          
Financial assets and liabilities measured at fair value on recurring basis          
Development milestone payments which the entity is obligated to pay 40,000,000   $ 40,000,000    
Non-collaborative Arrangement Transactions | Agilis | Commitments          
Financial assets and liabilities measured at fair value on recurring basis          
Development milestone payments which the entity is obligated to pay $ 40,000,000